Intercept Pharmaceuticals (ICPT) PT Lowered to $57 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Intercept Pharma (ICPT) Misses Q4 EPS by 88c, Miss on Revenues
February 14, 2018 7:12 AM ESTNote: EPS may not comparable
Intercept Pharma (NASDAQ: ICPT) reported Q4 EPS of ($4.43), $0.88 worse than the analyst estimate of ($3.55). Revenue for the quarter came in at $37.3 million versus the consensus estimate of $39.03 million.
Worldwide Net Ocaliva® (obeticholic acid or OCA) full year 2017 net sales of... More